also says buy opportunity
The Fly On The Wall News Stream12/24/14
The next big thing in oncology (JUNO )
Juno's lead candidate, JCAR015, is a treatment for acute lymphoblastic leukemia (ALL), the stellar results of which led the FDA to grant a breakthrough therapy designation last month, promising an expedited regulatory review.
this is extremely undervalued.
Dec 8, 2014
Adam Feuerstein @adamfeuerstein ·
$BLUE LentiGlobin updated data spectacular. 4/7 b-thal pats transfusion indpt w/ 3 mos. follow. Rest on way. Story post in a minute. #ASH14
right back up.
I do know granting stock options right before news is very bullish and a reward when good news is coming out CEO was granted 345K
The New York Times reported earlier Friday evening a deal could be announced. The plans are not finalized and talks could still break up, the people said.